Patient warned by GP after selling prescribed drugs online

A GP contacted the MDU’s advice line because a member of the practice team had noticed a Facebook page in which a patient of the practice appeared to be selling prescribed drugs including diazepam and oxycodone.

Most prescription drugs can only be legally supplied by a pharmacy, but doctors have contacted us with concerns that patients may be selling prescribed drugs online. The following anonymised case is based on cases where the MDU has supported members who have concerns about this issue.

The scene

A GP contacted the MDU's advice line because a member of the practice team had noticed a Facebook page in which a patient of the practice appeared to be selling prescribed drugs including diazepam and oxycodone. On checking the patient's notes the GP saw the patient had received repeat prescriptions of the drugs for a number of years.

It wasn't clear from the content of the website whether the patient was responsible for the page, but a person who the GP believed to be the patient's girlfriend had liked the page. The GP asked the MDU what she should do and whether she should tell the police.

The MDU adviser suggested that the GP should liaise with her colleagues to discuss the patient with those doctors that had seen him. The other doctors in the practice confirmed that the patient regularly attended for reviews of his medication and had never asked for replacement prescriptions. There was nothing to suggest he was not using his medications as intended.

The patient was asked in for a meeting to discuss the GP's concerns. At the meeting, the patient initially denied selling his medications, however, after the GP mentioned the girlfriend's apparent endorsement, he admitted doing so.

The GP planned to ask the patient for his consent for her to inform the police about the allegations but she felt it was unlikely he would agree.

MDU advice

In situations such as this the GP would need to consider whether disclosure could be justified in the public interest. This decision is essentially a balancing act between the benefits to an individual or society of disclosing versus the harms to the doctor/patient relationship of disclosure.

Disclosure in the public interest without consent, or after refusal of consent, may be justified if failure to make the disclosure could expose others to a risk of serious harm or death. This could arise where disclosure might assist in the prevention, detection or prosecution of a serious crime, as outlined in paragraphs 60-70 of the GMC's Confidentiality guidance.

This guidance does not provide a specific definition of 'serious crime', but on page 35 of the Department of Health guidance 'Confidentiality: NHS Code of Practice' (2003) the examples listed are murder, manslaughter, rape, child abuse, substantial financial gain/loss and risk of state security/public order.

The outcome

The GP had also been told by a family member that the patient was selling the drugs to children. She concluded that a failure to inform the police of these allegations would leave individuals, and children in particular, at serious risk.

The member explained to the patient that she would be informing the police about the drug selling, providing the minimum information necessary. At a second meeting, the patient said he had stopped selling the drugs online. The GP established how much medication the patient was actually using and a plan was made to adjust the prescription including the frequency of collection and dose reductions. The GP also informed him that his behaviour was detrimental to the ongoing doctor-patient relationship and that a warning letter would follow their meeting.

The GP was advised by the MDU to carefully document her discussions with the patient, including his confession, the reasons for her decisions and her clinical management plan.

This page was correct at publication on 23/04/2018. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.


Login to comment

Be the first to comment